Neil Sebire is Professor of pathology at Great Ormond Street Hospital Institute of child health. He is an active clinical academic, having co-authored >1000 publications (h-index 108), with a particular interest over recent years in clinical informatics and making secondary use of routine health data. He is the chief research information officer at Great Ormond Street Hospital and was the inaugural national chief clinical data officer for health data research UK (HDRUK). He runs the GOSH clinical informatics research program which currently has more than 20 PhD students working in this area.

Associate Professor Mark Cowley is Deputy Director, Enabling Platforms and Collaboration at Children’s Cancer Institute (CCI). He joined CCI in 2018 to head the Computational Biology Group, and is also co-head of the Luminesce Alliance Data Enabling Platform, president of AGTA (peak genomics body in the region) and co-head of the ACRF Child Cancer Liquid Biopsy Program. Mark is the Genome Informatics and Data Enabling Platforms lead for the Zero Childhood Cancer Program, overseeing creation of novel analytical approaches and systems that enable real-time analysis of Whole Genome, Transcriptome and Methylome data for every childhood cancer patient in Australia. Mark has been an early adopter of sequencing methods in Australia, establishing some of the world’s first clinically accredited WGS-based diagnostic tests. Mark’s recent projects, many supported by the Luminesce Alliance, have improved analysis of children’s cancer data, producing tools to detect features such as non-coding, splicing, mitochondrial and structural mutations.

Tom Snelling is a clinical scientist, Director of Health and Clinical Analytics in the School of Public Health at the University of Sydney, and an infectious diseases physician in the Sydney Children’s Hospitals Network. Tom has particular interest in vaccine preventable diseases and application of decision theory to research design. He leads a team of researchers aiming to improve healthcare and reduce the burden of infectious disease by implementing learning health systems. Tom applies Bayesian approaches to the design, implementation, and analysis of public health studies, and is successfully leading a suite of multi-institutional collaborative projects across Australia covering a range of clinical domains. These include improving treatment and prevention of severe gastroenteritis in remote Aboriginal children, primary prevention of food allergies in children, SMS text messages to improve timeliness of routine immunisation, and improving management of cystic fibrosis.

Professor Natasha Nassar is a perinatal and paediatric epidemiologist, the Financial Markets Foundation for Children Chair in Translational Childhood Medicine and NHMRC Investigator Fellow at the Children’s Hospital at Westmead (CHW) Clinical School, University of Sydney. She is also the Data Lead of the Menzies Centre for Health Policy and Economics and the Charles Perkins Centre Populations Domain Leader with a key role in facilitating population-based research investigating cardiovascular disease, obesity, diabetes and other related conditions across a wide range of disciplines. Her research takes a lifespan approach that focuses on understanding early life determinants, perinatal care and childhood conditions on long-term child health and well-being. This involves the use data linkage of clinical, registry and administrative birth, state and Commonwealth health and education datasets to establish statewide birth data cohorts that enable longitudinal follow-up of children over time. These linked data platforms have enabled the investigation of real-world clinical and policy questions of health outcomes, wellbeing, health service utilisation and costs to the health system across the lifespan.

Dr. Warren Kaplan is the Science Lead for Genomics and Biomedical Data at NCI Australia. He leads the computational medicine pillar at NCI, where key projects include the $185 million Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) and the building of Australia’s National Genomics Archive. After completing a structural biology PhD at Wits University in 1998, he joined Entigen (a bioinformatics start-up company), where he worked as a molecular modeller and bioinformatics programmer. He moved to the Garvan Institute of Medical Research as bioinformatics hire number one in 2002, and in his 20 years at Garvan, he ran the Peter Wills Bioinformatics Centre, was appointed to the roles of Chief of Informatics and subsequently. Head of the Data Sciences Platform that worked in production workflows, application development, High-Performance Computing, and Big Data infrastructure.

Dr Teresa Anderson AM, Chief Executive, Single Digital Patient Record Implementation Authority. Dr Anderson has more than 35 years of extensive experience as a senior health service manager. She has a well-established reputation for implementing strategies focused on fostering partnerships, supporting the delivery of innovative, patient centred, best practice health care. Dr Anderson was the Chief Executive of Sydney Local Health District for over 13 years. She is a Speech Pathologist, internationally recognised for her specialist knowledge and skills in the research, assessment and management of paediatric and adult dysphagia, early communication development, early childhood development and early intervention. She is a member of the Australian Eating Disorders, Research and Translation Centre Governing Council, a board member of the Centre for Primary Health Care Equity and the Institute of Public Administration Australia NSW. In the 2018 Queen’s Birthday Honours, Dr Anderson was made a Member of the Order of Australia for her service to community health and to public administration in NSW as a clinician, manager and health service executive.

Neil Sebire is Professor of pathology at Great Ormond Street Hospital Institute of child health. He is an active clinical academic, having co-authored >1000 publications (h-index 108), with a particular interest over recent years in clinical informatics and making secondary use of routine health data. He is the chief research information officer at Great Ormond Street Hospital and was the inaugural national chief clinical data officer for health data research UK (HDRUK). He runs the GOSH clinical informatics research program which currently has more than 20 PhD students working in this area.

Associate Professor Mark Cowley is Deputy Director, Enabling Platforms and Collaboration at Children’s Cancer Institute (CCI). He joined CCI in 2018 to head the Computational Biology Group, and is also co-head of the Luminesce Alliance Data Enabling Platform, president of AGTA (peak genomics body in the region) and co-head of the ACRF Child Cancer Liquid Biopsy Program. Mark is the Genome Informatics and Data Enabling Platforms lead for the Zero Childhood Cancer Program, overseeing creation of novel analytical approaches and systems that enable real-time analysis of Whole Genome, Transcriptome and Methylome data for every childhood cancer patient in Australia. Mark has been an early adopter of sequencing methods in Australia, establishing some of the world’s first clinically accredited WGS-based diagnostic tests. Mark’s recent projects, many supported by the Luminesce Alliance, have improved analysis of children’s cancer data, producing tools to detect features such as non-coding, splicing, mitochondrial and structural mutations.

Tom Snelling is a clinical scientist, Director of Health and Clinical Analytics in the School of Public Health at the University of Sydney, and an infectious diseases physician in the Sydney Children’s Hospitals Network. Tom has particular interest in vaccine preventable diseases and application of decision theory to research design. He leads a team of researchers aiming to improve healthcare and reduce the burden of infectious disease by implementing learning health systems. Tom applies Bayesian approaches to the design, implementation, and analysis of public health studies, and is successfully leading a suite of multi-institutional collaborative projects across Australia covering a range of clinical domains. These include improving treatment and prevention of severe gastroenteritis in remote Aboriginal children, primary prevention of food allergies in children, SMS text messages to improve timeliness of routine immunisation, and improving management of cystic fibrosis.

Professor Natasha Nassar is a perinatal and paediatric epidemiologist, the Financial Markets Foundation for Children Chair in Translational Childhood Medicine and NHMRC Investigator Fellow at the Children’s Hospital at Westmead (CHW) Clinical School, University of Sydney. She is also the Data Lead of the Menzies Centre for Health Policy and Economics and the Charles Perkins Centre Populations Domain Leader with a key role in facilitating population-based research investigating cardiovascular disease, obesity, diabetes and other related conditions across a wide range of disciplines. Her research takes a lifespan approach that focuses on understanding early life determinants, perinatal care and childhood conditions on long-term child health and well-being. This involves the use data linkage of clinical, registry and administrative birth, state and Commonwealth health and education datasets to establish statewide birth data cohorts that enable longitudinal follow-up of children over time. These linked data platforms have enabled the investigation of real-world clinical and policy questions of health outcomes, wellbeing, health service utilisation and costs to the health system across the lifespan.